Skip to main content
. Author manuscript; available in PMC: 2014 Sep 3.
Published in final edited form as: Cancer Res. 2014 May 8;74(14):3913–3922. doi: 10.1158/0008-5472.CAN-14-0247

Table 3. Cytotoxicity (IC50, μM) of cisplatin, dissolved or suspended in solvents, against DLD-1 cells.

Cisplatin IC50 (μM) Stock (μM) Soluble 3% solvent viability (%)
Control 100
Clinical 3.3 ± 0.5 3.3 Y -
Saline 3.8 ± 0.6 3.3 Y 96 ± 10
DMSO 177.6 ± 9.2 20 Y 90 ± 5
DMF 5.0 ± 1.3 10 Y 79 ± 5
DMA 3.5 ± 0.8 10 Y 24 ± 3
Formamide 3.7 ± 1.8 10 Y 57 ± 2
Cremophor EL 2.5 ± 0.2 10 N 0.7 ± 0.1
Acetonitrile 3.4 ± 0.3 10 N 103 ± 6
Water 4.0 ± 0.5 3.3 Y 106 ± 7